EP2126580A4 - Reagentien zum nachweis der proteinphosphorylierung in leukämie-signalwegen - Google Patents

Reagentien zum nachweis der proteinphosphorylierung in leukämie-signalwegen

Info

Publication number
EP2126580A4
EP2126580A4 EP06718094A EP06718094A EP2126580A4 EP 2126580 A4 EP2126580 A4 EP 2126580A4 EP 06718094 A EP06718094 A EP 06718094A EP 06718094 A EP06718094 A EP 06718094A EP 2126580 A4 EP2126580 A4 EP 2126580A4
Authority
EP
European Patent Office
Prior art keywords
reagents
detection
signaling pathways
protein phosphorylation
leukemia signaling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06718094A
Other languages
English (en)
French (fr)
Other versions
EP2126580A2 (de
Inventor
Valerie Goss
Albrecht Moritz
Ting-Lei Gu
Kimberly Lee
Roberto Polakiewicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cell Signaling Technology Inc
Original Assignee
Cell Signaling Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Signaling Technology Inc filed Critical Cell Signaling Technology Inc
Publication of EP2126580A2 publication Critical patent/EP2126580A2/de
Publication of EP2126580A4 publication Critical patent/EP2126580A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EP06718094A 2005-02-10 2006-01-12 Reagentien zum nachweis der proteinphosphorylierung in leukämie-signalwegen Withdrawn EP2126580A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65158305P 2005-02-10 2005-02-10
PCT/US2006/000979 WO2006086111A2 (en) 2005-02-10 2006-01-12 Reagents for the detection of protein phosphorylation in leukemia signaling pathways

Publications (2)

Publication Number Publication Date
EP2126580A2 EP2126580A2 (de) 2009-12-02
EP2126580A4 true EP2126580A4 (de) 2010-11-10

Family

ID=36793552

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06718094A Withdrawn EP2126580A4 (de) 2005-02-10 2006-01-12 Reagentien zum nachweis der proteinphosphorylierung in leukämie-signalwegen

Country Status (2)

Country Link
EP (1) EP2126580A4 (de)
WO (1) WO2006086111A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007064647A2 (en) 2005-12-01 2007-06-07 New York Blood Center, Inc. Peptide inhibitors of abl kinases
WO2008153636A1 (en) * 2007-05-04 2008-12-18 Cellsignaling Technology, Inc. Phospho-specific antibodies to p13k regulatory subunit and uses thereof
CN101802182A (zh) 2007-08-21 2010-08-11 诺达利蒂公司 用于诊断、预后和治疗方法的方法
WO2010006291A1 (en) 2008-07-10 2010-01-14 Nodality, Inc. Methods for diagnosis, prognosis and treatment
US8399206B2 (en) 2008-07-10 2013-03-19 Nodality, Inc. Methods for diagnosis, prognosis and methods of treatment
AU2011261107B2 (en) 2010-05-31 2016-04-14 London Health Sciences Centre Research Inc. RHAMM binding peptides
DE102010033575B4 (de) * 2010-08-02 2016-01-14 Eberhard-Karls-Universität Tübingen Universitätsklinikum ASPP2-Splicevariante
GB201322574D0 (en) * 2013-12-19 2014-02-05 Equigerminal Sa Retroviral peptides
WO2020097096A1 (en) * 2018-11-05 2020-05-14 The Brigham And Women's Hospital, Inc. Nedd9 in pulmonary vascular thromboembolic disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070899A2 (en) * 2002-02-20 2003-08-28 Cell Signaling Technology, Inc. Phospho-specific antibodies to flt3 and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599305A (en) * 1984-07-16 1986-07-08 The Regents Of The University Of California Method and composition for detection of human chronic myelogenous leukemia
US5667981A (en) * 1994-05-13 1997-09-16 Childrens Hospital Of Los Angeles Diagnostics and treatments for cancers expressing tyrosine phosphorylated CRKL protein

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070899A2 (en) * 2002-02-20 2003-08-28 Cell Signaling Technology, Inc. Phospho-specific antibodies to flt3 and uses thereof

Also Published As

Publication number Publication date
WO2006086111A3 (en) 2009-04-16
EP2126580A2 (de) 2009-12-02
WO2006086111A2 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
EP1929003A4 (de) Reagentien zum nachweis von proteinphosphorylierung in karzinom-signalwegen
EP2126580A4 (de) Reagentien zum nachweis der proteinphosphorylierung in leukämie-signalwegen
EP2036119A4 (de) Dreidimensionale integrierte schaltung zur analytdetektion
EP1974199A4 (de) Erfassungssystem
EP1908496A4 (de) Positionserfassungssystem
EP1950554A4 (de) Gemischidentifizierungssystem
EP1942314A4 (de) Navigationssystem
EP1745612A4 (de) Weganalysesystem
EP1932463A4 (de) Positionserfassungssystem
EP1858537A4 (de) Prion-spezifische peptid-reagenzien
EP1844320A4 (de) Fluoreszenznachweissystem
DE602005011891D1 (de) System zur Erkennung dreidimensionaler Gegenstände
GB0512743D0 (en) Range detection
EP1852322A4 (de) System zur bewertung von teilen am fahrzeug
GB0504500D0 (en) Signal processing arrangement
EP1958341A4 (de) Echoerkennung
EP1938102A4 (de) Verbesserter zielligandennachweis
EP1891563A4 (de) Verteiltes analysesystem
EP1845838A4 (de) Wissensbestimmungssystem
GB0504552D0 (en) Signal detection techniques
GB0510916D0 (en) Detection system
GB2432211B (en) Agglutination based assay system
EP1872134A4 (de) Reagentien zum nachweis von proteinphosphorylierung in karzinom-signalwegen
GB2459218B (en) Underwater signal direction determination
EP1934614A4 (de) Reagentien zum nachweis von proteinphosphorylierung in karzinom-signalwegen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071123

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20101013

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110503